secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2025-06-30T23:59:59+00:00
Accession:  0001104659-25-064144
Event type: regulatory
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq grants Entero Therapeutics extension to Oct 8, 2025 to meet minimum equity requirement
--------------------------------------------------------------------------------

- Company received Nasdaq extension letter on June 25, 2025; deadline to regain compliance is October 8, 2025.
- Must meet Nasdaq Rule 5550(b)(1) minimum stockholders' equity of $2.5 million.
- As of Dec 31, 2024, stockholders' equity was negative $3.88 million, triggering the deficiency.
- Failure to regain compliance may result in delisting, but appeal to a Nasdaq Hearing Panel is permitted.
- No assurance that compliance will be achieved or listing maintained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925064144/0001104659-25-064144-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925064144/tm2519504d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-064144

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer